Danisová A, Scsuková S, Matulová L, Orlický J, Kolena J
Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovak Republic.
Physiol Res. 1995;44(3):185-92.
Intrafollicular luteinization stimulator was shown to be secreted by granulosa cells in culture with stimulatory effects on differentiation of immature granulosa cells. The purpose of this study was to evaluate the role of calcium ions in luteinization stimulator-enhanced luteinization process of granulosa cells. We examined the direct effect of ionophore A23187, voltage-sensitive Ca(2+)-channel blockers verapamil, nimodipine, nifedipine, niludipine and calmodulin antagonist trifluoroperazine on progesterone and cGMP levels in 3-day culture of small granulosa cells. It was shown that the dihydropyridine derivates of calcium blocker drugs (nimodipine, nifedipine, niludipine) and calmodulin antagonist (trifluoroperazine) in the micromolar range, significantly suppressed FSH-induced progesterone synthesis and cGMP accumulation in granulosa cells. On the contrary, phenylalkylamine calcium blocker verapamil and calcium ionophore A23187 had different effects on both processes. Calcium ionophore A23187 markedly enhanced cGMP formation, but simultaneously inhibited the FSH-induced progesterone synthesis. Verapamil at lower concentrations (10 microM) stimulated and at higher concentrations (50 microM) inhibited the formation of cGMP. To evaluate the role of extra- and intracellular calcium in luteinization stimulator-enhanced progesterone production by small granulosa cells, the effects of indicative agents on stimulatory activity of follicular fluid from large follicles, granulosa cells-conditioned media and granulosa cell extracts were tested. While verapamil is shown to be a less potent modulator, administration of other calcium antagonists as well as ionophore A23187 caused a significant decrease in stimulatory action of follicular fluid from large follicles, granulosa cells-conditioned media and extracts. These findings indicate that the stimulatory action of luteinization stimulator depends on the transport of calcium ions through voltage-sensitive calcium channels and is modulated by alteration of intracellular calcium levels.
卵泡内黄体化刺激因子已被证明是由培养的颗粒细胞分泌的,对未成熟颗粒细胞的分化具有刺激作用。本研究的目的是评估钙离子在黄体化刺激因子增强颗粒细胞黄体化过程中的作用。我们检测了离子载体A23187、电压敏感性钙通道阻滞剂维拉帕米、尼莫地平、硝苯地平、尼鲁地平以及钙调蛋白拮抗剂三氟拉嗪对小颗粒细胞3天培养物中孕酮和环磷酸鸟苷(cGMP)水平的直接影响。结果表明,微摩尔浓度范围内的钙通道阻滞剂药物(尼莫地平、硝苯地平、尼鲁地平)的二氢吡啶衍生物以及钙调蛋白拮抗剂(三氟拉嗪)显著抑制了促卵泡激素(FSH)诱导的颗粒细胞孕酮合成和cGMP积累。相反,苯烷基胺类钙通道阻滞剂维拉帕米和钙离子载体A23187对这两个过程有不同的影响。钙离子载体A23187显著增强了cGMP的形成,但同时抑制了FSH诱导的孕酮合成。较低浓度(10微摩尔)的维拉帕米刺激cGMP的形成,而较高浓度(50微摩尔)则抑制其形成。为了评估细胞外和细胞内钙在黄体化刺激因子增强小颗粒细胞孕酮产生中的作用,测试了指示剂对大卵泡卵泡液、颗粒细胞条件培养基和颗粒细胞提取物刺激活性的影响。虽然维拉帕米被证明是一种作用较弱的调节剂,但其他钙拮抗剂以及离子载体A23187的使用导致大卵泡卵泡液、颗粒细胞条件培养基和提取物的刺激作用显著降低。这些发现表明,黄体化刺激因子的刺激作用取决于钙离子通过电压敏感性钙通道的转运,并受到细胞内钙水平变化的调节。